Medicare will begin covering certain GLP-1 drugs for a $50 copay starting July 1, but for now the program isn't permanent.
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results